These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 24862093
1. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir. Murphy DJ, Desjardins D, Dereuddre-Bosquet N, Brochard P, Perrot L, Pruvost A, Le Grand R, Lagatie O, Vanhooren L, Feyaerts M, van Roey J, Malcolm RK. J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093 [Abstract] [Full Text] [Related]
4. Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES. McBride JW, Malcolm RK, Dias N, Cameron D, Offord RE, Hartley O, Kett VL, Devlin B, Boyd P. Int J Pharm; 2019 Jun 10; 564():207-213. PubMed ID: 30999049 [Abstract] [Full Text] [Related]
5. The sheep as a model of preclinical safety and pharmacokinetic evaluations of candidate microbicides. Holt JD, Cameron D, Dias N, Holding J, Muntendam A, Oostebring F, Dreier P, Rohan L, Nuttall J. Antimicrob Agents Chemother; 2015 Jul 10; 59(7):3761-70. PubMed ID: 25845860 [Abstract] [Full Text] [Related]
10. Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance. Murphy DJ, Lim D, Armstrong R, McCoy CF, Bashi YHD, Boyd P, Derrick T, Spence P, Devlin B, Malcolm RK. Drug Deliv Transl Res; 2023 Aug 14; 13(8):2072-2082. PubMed ID: 34674162 [Abstract] [Full Text] [Related]
12. Pharmacokinetic assessment of dapivirine vaginal microbicide gel in healthy, HIV-negative women. Nel AM, Coplan P, Smythe SC, McCord K, Mitchnick M, Kaptur PE, Romano J. AIDS Res Hum Retroviruses; 2010 Nov 14; 26(11):1181-90. PubMed ID: 20854207 [Abstract] [Full Text] [Related]
16. A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine. Major I, Boyd P, Kilbourne-Brook M, Saxon G, Cohen J, Malcolm RK. Contraception; 2013 Jul 14; 88(1):58-66. PubMed ID: 23177261 [Abstract] [Full Text] [Related]
18. Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women. Bunge KE, Levy L, Szydlo DW, Zhang J, Gaur AH, Reirden D, Mayer KH, Futterman D, Hoesley C, Hillier SL, Marzinke MA, Hendrix CW, Gorbach PM, Wilson CM, Soto-Torres L, Kapogiannis B, Nel A, Squires KE, MTN-023/IPM 030 Study Team. J Acquir Immune Defic Syndr; 2020 Feb 01; 83(2):135-139. PubMed ID: 31929401 [Abstract] [Full Text] [Related]
19. Post-use assay of vaginal rings (VRs) as a potential measure of clinical trial adherence. Spence P, Nel A, van Niekerk N, Derrick T, Wilder S, Devlin B. J Pharm Biomed Anal; 2016 Jun 05; 125():94-100. PubMed ID: 27016673 [Abstract] [Full Text] [Related]
20. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV-1 acquisition: a secondary analysis from a randomized, placebo-controlled trial. Brown ER, Hendrix CW, van der Straten A, Kiweewa FM, Mgodi NM, Palanee-Philips T, Marzinke MA, Bekker LG, Soto-Torres L, Hillier SL, Baeten JM, MTN-020/ASPIRE Study Team. J Int AIDS Soc; 2020 Nov 05; 23(11):e25634. PubMed ID: 33206462 [Abstract] [Full Text] [Related] Page: [Next] [New Search]